phase readout
saveNCT03543969: Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
ACTIVE_NOT_RECRUITINGupdated 10d ago
community read0 votes
Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: EARLY_PHASE1. Conditions: Melanoma (Skin), Skin Cancer, Skin Melanoma, Skin Carcinoma
view source ↗
comments(0)
5-min edit window · permanent after that